查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448760

全球即時 PCR、數位 PCR 和終點 PCR 市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Real-time PCR, Digital PCR, And End-point PCR Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 292 Pages | 商品交期: 最快1-2個工作天內

價格

全球即時 PCR、數位 PCR 和終點 PCR 市場需求預計將從 2023 年的 81.6 億美元增至 2032 年的近 128.1 億美元，2024 年研究期間複合CAGR為 5.14% - 2032.

聚合酶鍊式反應 (PCR) 是一種用於擴增和分析 DNA 的分子生物學技術。 PCR 有多種變體，包括即時 PCR、數位 PCR 和終點 PCR，每種都有自己的應用和優點。

市場動態

由於 PCR 技術在 COVID-19 檢測中的關鍵作用，全球對 PCR 技術的需求激增。這次大流行凸顯了檢測 SARS-CoV-2 病毒遺傳物質的重要性。除了傳染病診斷之外，PCR 仍然是分子診斷的基石，有助於其擴展。生命科學研究的進步，特別是基因組學和蛋白​​質組學的進步，進一步推動了對該技術的需求。遺傳性疾病病例的增加以及對精確和早期診斷的需求推動了基於 PCR 的方法在基因檢測中的採用。即時 PCR 和數位 PCR 等技術的不斷進步提高了 DNA 擴增的效率和靈敏度，從而促進了市場成長。此外，對即時檢測解決方案的需求以及攜帶式 PCR 技術在快速診斷中的應用也有助於市場的擴張。在製藥和生物技術行業，PCR 是藥物開發、發現和品質控制不可或缺的一部分，進一步推動了其市場佔有率。隨著 PCR 不斷發展並在不同領域找到應用，其市場預計將持續成長，以適應不斷變化的診斷和研究需求。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球即時 PCR、數位 PCR 和終點 PCR 市場的各個細分市場進行了包容性評估。即時 PCR、數位 PCR 和終點 PCR 產業的成長和趨勢為本研究提供了整體方法。

市場區隔

即時 PCR、數位 PCR 和終點 PCR 市場報告的這一部分提供了國家和區域層級細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依技術

  • 定量
  • 數位的
  • 終點

按產品分類

  • 耗材及試劑
  • 儀器
  • 軟體與服務

按應用類型

  • 臨床（病原體檢測、腫瘤學檢測、血液篩檢、液體活體組織切片、基於 Dpcr 的非侵入性產前檢測 (Nipt) 等）
  • 研究（幹細胞研究、DNA 克隆和定序、重組 DNA 技術、罕見突變檢測、基因表現、單細胞分析、微生物組分析、拷貝數變異分析、文庫定量 (NGS)、mRNA 和 miRNA 低倍變化的表徵、基因改造生物檢測）
  • 法醫

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲即時 PCR、數位 PCR 和終點 PCR 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。即時 PCR、數位 PCR 和終點 PCR 市場的主要參與者包括 Abbott、Qiagen、Bio-Rad Laboratories Inc.、Agilent Technologies, Inc.、Thermo Fisher Scientific, Inc.、GE Healthcare、bioMerieux、F . Hoffmann-La Roche Ltd 、Fluidigm Corporation。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：即時 PCR、數位 PCR 和終點 PCR - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按應用類型分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球即時 PCR、數位 PCR 和終點 PCR 市場分析：按技術分類

  • 依技術概述
  • 歷史和預測數據
  • 依技術分析
  • 定量
  • 數位的
  • 終點

第 6 章：全球即時 PCR、數位 PCR 和終點 PCR 市場分析：依產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 耗材及試劑
  • 儀器
  • 軟體與服務

第 7 章：全球即時 PCR、數位 PCR 和終點 PCR 市場分析：按應用類型

  • 按應用程式類型概述
  • 歷史和預測數據
  • 按應用程式類型分析
  • 臨床（病原體檢測、腫瘤學檢測、血液篩檢、液體活體組織切片、基於 dPCR 的非侵入性產前檢測 (NIPT) 等）
  • 研究（幹細胞研究、DNA 克隆和定序、重組 DNA 技術、罕見突變檢測、基因表現、單細胞分析、微生物組分析、拷貝數變異分析、文庫定量 (NGS)、mRNA 和 miRNA 低倍變化的表徵、基因改造生物檢測）
  • 法醫

第 8 章：全球即時 PCR、數位 PCR 和終點 PCR 市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：即時 PCR、數位 PCR 和終點 PCR 公司的競爭格局

  • 即時PCR、數位PCR和終點PCR市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Abbott
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Qiagen
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Rad Laboratories Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Agilent Technologies Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GE Healthcare
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • bioMerieux
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche Ltd
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Fluidigm Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113580

The global demand for Real-time PCR, Digital PCR, And End-point PCR Market is presumed to reach the market size of nearly USD 12.81 BN by 2032 from USD 8.16 BN in 2023 with a CAGR of 5.14% under the study period 2024 - 2032.

Polymerase Chain Reaction (PCR) is a molecular biology technique used to amplify and analyze DNA. There are several variations of PCR, including real-time PCR, digital PCR, and endpoint PCR, each with its own applications and advantages.

MARKET DYNAMICS

The global demand for PCR technology has surged due to its pivotal role in COVID-19 testing. The pandemic has highlighted its importance in detecting the genetic material of the SARS-CoV-2 virus. Beyond infectious disease diagnostics, PCR remains a cornerstone in molecular diagnostics, contributing to its expansion. Advances in life sciences research, particularly in genomics and proteomics, further fuel the demand for this technology. The rising cases of genetic disorders and the need for precise and early diagnosis propel the adoption of PCR-based methods in genetic testing. Continuous technological advancements, including real-time PCR and digital PCR, enhance the efficiency and sensitivity of DNA amplification, reinforcing market growth. Additionally, the demand for point-of-care testing solutions and the application of portable PCR technologies in rapid diagnostics contribute to the market's expansion. In the pharmaceutical and biotechnology industries, PCR is integral for drug development, discovery, and quality control, further driving its market presence. As PCR continues to evolve and find applications across diverse sectors, its market growth is expected to persist, adapting to the changing landscape of diagnostic and research needs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of real-time pcr, digital pcr, and end-point pcr. The growth and trends of real-time pcr, digital pcr, and end-point pcr industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the real-time pcr, digital pcr, and end-point pcr market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • Quantitative
  • Digital
  • End-Point

By Product

  • Consumables & Reagents
  • Instruments
  • Software & Services

By Application Type

  • Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, Dpcr-Based Non-Invasive Prenatal Testing (Nipt), Others)
  • Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection)
  • Forensic

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Real-time PCR, Digital PCR, And End-point PCR market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Real-time PCR, Digital PCR, And End-point PCR market include Abbott, Qiagen, Bio-Rad Laboratories Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, bioMerieux, F. Hoffmann-La Roche Ltd, Fluidigm Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application Type
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY TECHNOLOGY

  • 5.1 Overview by Technology
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Technology
  • 5.4 Quantitative Historic and Forecast Sales by Regions
  • 5.5 Digital Historic and Forecast Sales by Regions
  • 5.6 End-point Historic and Forecast Sales by Regions

6 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Consumables & Reagents Historic and Forecast Sales by Regions
  • 6.5 Instruments Historic and Forecast Sales by Regions
  • 6.6 Software & Services Historic and Forecast Sales by Regions

7 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY APPLICATION TYPE

  • 7.1 Overview by Application Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application Type
  • 7.4 Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, dPCR-based Non-Invasive Prenatal Testing (NIPT), Others) Historic and Forecast Sales by Regions
  • 7.5 Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection) Historic and Forecast Sales by Regions
  • 7.6 Forensic Historic and Forecast Sales by Regions

8 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR COMPANIES

  • 9.1. Real-Time Pcr, Digital Pcr, And End-Point Pcr Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Qiagen
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Bio-Rad Laboratories Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Agilent Technologies Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Thermo Fisher Scientific Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. GE Healthcare
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. bioMerieux
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. F. Hoffmann-La Roche Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Fluidigm Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Technology (USD MN)
  • Quantitative Market Sales by Geography (USD MN)
  • Digital Market Sales by Geography (USD MN)
  • End-point Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Consumables & Reagents Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Software & Services Market Sales by Geography (USD MN)
  • Analysis by Application Type (USD MN)
  • Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, dPCR-based Non-Invasive Prenatal Testing (NIPT), Others) Market Sales by Geography (USD MN)
  • Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection) Market Sales by Geography (USD MN)
  • Forensic Market Sales by Geography (USD MN)
  • Global Real-Time Pcr, Digital Pcr, And End-Point Pcr Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Real-Time Pcr, Digital Pcr, And End-Point Pcr Report
  • Market Research Process
  • Market Research Methodology
  • Global Real-Time Pcr, Digital Pcr, And End-Point Pcr Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Technology (USD MN)
  • Quantitative Market Sales by Geography (USD MN)
  • Digital Market Sales by Geography (USD MN)
  • End-point Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Consumables & Reagents Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Software & Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Application Type (USD MN)
  • Clinical (Pathogen Testing, Oncology Testing, Blood Screening, Liquid Biopsy, dPCR-based Non-Invasive Prenatal Testing (NIPT), Others) Market Sales by Geography (USD MN)
  • Research (Stem Cell Research, DNA Cloning & Sequencing, Recombinant DNA Technology, Rare Mutation Detection, Gene Expression, Single Cell Analysis, Microbiome Analysis, Copy Number Variation Analysis, Library Quantification (NGS), Characterization of Low-fold Changes in mRNA and miRNA, GMO Detection) Market Sales by Geography (USD MN)
  • Forensic Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.